Pharma & Biotech

The biotechnology sector thrives on breakthrough innovation, and Xencor stands at a pivotal juncture with multiple advanced clinical programs approaching...

Medical technology firm Semler Scientific faces a growing wave of investor litigation following revelations about a long-concealed Department of Justice...

Eli Lilly and Company shares are currently exhibiting a classic technical consolidation pattern, caught between well-defined support and resistance levels....

Shares of German biotechnology firm BioNTech faced renewed pressure on Friday following a media report examining potential COVID-19 vaccine side...

Esperion Therapeutics has captured significant market attention with a remarkable upward surge in its share price. The biopharmaceutical company's recent...

Merck KGaA's recent $3.9 billion acquisition of SpringWorks Therapeutics is demonstrating immediate strategic value, with European regulators granting marketing authorization...

Entrada Therapeutics, once a promising biotech contender, now finds itself navigating turbulent market conditions. Current shareholders are facing substantial erosion...

Capricor Therapeutics finds itself at a critical juncture, with its shares embodying a stark contrast between ambitious analyst projections and...

The future of clinical-stage pharmaceutical company HilleVax will be determined on Monday as the takeover bid from biotechnology specialist XOMA...

Soleno Therapeutics finds itself navigating turbulent waters after reports emerged of a patient fatality connected to its lead drug candidate,...